Orthopedic device companies have been actively developing products for surgical robotics, several through acquisitions.

Stryker’s success with its Mako robot-assisted surgery platform has other orthopedic device companies hastening to enter the space. The big question is whether long-term outcomes will justify the expensive technology.

If an enterprising firm set up a mutual fund reflecting the worldwide robotics industry, they might choose to separate their picks into three segments, which might look something like this: Industrial Robot Manufacturers Service Robot Makers of security, defense and space robots Service Robot Makers of robots for all other purposes Although I am neither…

By Frank Tobe, Editor and Publisher The Robot ReportA copy of this article also appeared on RoboticsTomorrow.com,IT Business Net, A New Domain Net and ECN Magazine.  “Pure play” is an investment term that refers to a company which is exclusively focused on a particular product or service. An investor buys stock in pure play companies…